Verastem stock trades at EUR 8.77 before results
Published on 11/05/2026 at 14:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSQuarterly results remain in focus
- Verastem is due to report its latest quarterly results on Thursday, November 5.
- The biotech focuses on medicines for cancers driven by RAS/MAPK signaling.
Verastem stock traded at 8.77 euros on Lang & Schwarz at 14:15 CET on Thursday, November 5, 2026.
The biotech is approaching its latest quarterly results, with the reporting date set for Thursday. Verastem focuses on medicines for cancers driven by RAS/MAPK signaling.
Results set the next catalyst
The upcoming report will give investors a fresh view of Verastem's operating progress and development pipeline. The company's oncology focus keeps clinical progress and financial execution central to the next update.
Investors can follow the real-time quote of Verastem stock on the trading page.
Verastem stock at a glance
- Company: Verastem, Inc.
- ISIN: US92337C2035
- Ticker: VSTM
- Trading venue: Lang & Schwarz
- Quote: 8.77 euros at 14:15 CET on Thursday, November 5, 2026
The Euro Stoxx 50 provides the broader European market context for investors.
More news and analyses on Verastem stock.
Disclaimer...
en | US92337C2035 | VSTM | boerse | 70464077 |
